It is tempting to speculate that this individual may have had cachexia at the time of sample collection where weight loss due to the increased glucose, lipid, and protein requirements of the tumor [36] could manifest as low BMI compounded with elevated urinary IL-1β as a result of advanced disease. This evidence concerns the gene IL1B and Cachexia.